Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Vext Science ( (TSE:VEXT) ) has issued an announcement.
Vext Science, Inc. reported record financial performance in Q2 2025, with revenue growing 59% year-over-year to $13.4 million, driven by strong momentum in Ohio and disciplined operations in Arizona. The company’s adjusted EBITDA more than tripled to $4.1 million, and operating cash flow reached $4.2 million, achieving a 31% cash flow margin, one of the highest in the industry. Vext is strengthening its retail footprint in Ohio, with plans to reach the state dispensary license cap by early 2026, positioning itself for sustained growth in the expanding adult-use market.
The most recent analyst rating on (TSE:VEXT) stock is a Buy with a C$0.50 price target. To see the full list of analyst forecasts on Vext Science stock, see the TSE:VEXT Stock Forecast page.
Spark’s Take on TSE:VEXT Stock
According to Spark, TipRanks’ AI Analyst, TSE:VEXT is a Neutral.
Vext Science’s overall score is driven by strong performance in the earnings call and strategic corporate events, highlighting growth opportunities. However, financial performance challenges and valuation concerns weigh on the score. Technical indicators suggest overbought conditions, which could temper short-term enthusiasm.
To see Spark’s full report on TSE:VEXT stock, click here.
More about Vext Science
Vext Science, Inc. is a U.S.-based cannabis operator with vertical operations in Arizona and Ohio. The company focuses on the cannabis industry, providing products and services related to cannabis retail and processing. Vext is expanding its market presence in Ohio and Arizona, aiming to capitalize on the growing adult-use market.
Average Trading Volume: 83,001
Technical Sentiment Signal: Buy
Current Market Cap: C$64.37M
Learn more about VEXT stock on TipRanks’ Stock Analysis page.